시장보고서
상품코드
1936797

레지오넬라 검사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

Global Legionella Testing Market Size, Share, Trends & Growth Analysis Report 2026-2034

발행일: | 리서치사: Value Market Research | 페이지 정보: 영문 149 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

레지오넬라균 검사 시장 규모는 2025년 3억 7,733만 달러에서 2034년에는 7억 7,335만 달러에 달할 것으로 예측되며, 2026년부터 2034년까지 CAGR 8.3%로 성장할 전망입니다.

레지오넬라균 검사 시장은 레지오넬라균과 관련된 건강 위험에 대한 인식이 높아지고 효과적인 검사 솔루션에 대한 수요가 증가함에 따라 큰 폭의 성장이 예상됩니다. 레지오넬라증 발병이 공중 보건에 대한 위협으로 떠오르면서 의료 시설, 상수도 관리 회사 및 규제 기관은 레지오넬라 오염을 감지하고 제어하기 위한 강력한 검사 프로토콜을 도입하는 것을 우선순위로 삼고 있습니다. 본 시장은 배양법, 중합효소 연쇄 반응(PCR) 검사, 신속 검사 키트 등 다양한 검사법을 포괄하고 있으며, 기술의 발전으로 결과의 정확도와 속도가 향상되고 있습니다.

또한, 수질 관리 및 안전 규제에 대한 관심이 높아지면서 레지오넬라 검사 시장에 영향을 미치고 있습니다. 정부와 보건 기관이 의료 시설, 호텔, 공공 건물의 급수 시스템에 대한 보다 엄격한 가이드라인을 제정함에 따라 신뢰할 수 있는 검사 솔루션에 대한 수요가 급증하고 있습니다. 이러한 추세에 따라 제조업체들은 규제 기준을 준수하고 물 관리에 실용적인 인사이트를 제공하는 혁신적인 검사 제품 개발을 추진하고 있습니다.

또한, 공중 보건의 예방 조치와 위험 평가에 대한 관심이 높아지면서 레지오넬라 검사 시장의 혁신이 촉진되고 있습니다. 검사 기관, 환경 보호 기관, 의료 서비스 제공자 간의 협력은 조사 방법과 기술 발전을 촉진하고 신제품이 각 분야의 진화하는 요구를 충족시킬 수 있도록 보장합니다. 레지오넬라균의 적극적인 관리가 감염 확산 방지에 중요하다는 인식이 높아진 것도 시장 성장에 기여하고 있습니다. 요약하면, 레지오넬라 검사 시장은 기술 발전, 규제 준수에 대한 관심, 공중 보건 안전 향상에 대한 노력으로 인해 견조한 성장을 보일 것으로 예상됩니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 레지오넬라 검사 시장 : 테스트 유형별

제5장 세계의 레지오넬라 검사 시장 : 용도별

제6장 세계의 레지오넬라 검사 시장 : 최종사용별

제7장 세계의 레지오넬라 검사 시장 : 지역별

제8장 경쟁 구도

제9장 기업 개요

KSM 26.03.11

The Legionella Testing Market size is expected to reach USD 773.35 Million in 2034 from USD 377.33 Million (2025) growing at a CAGR of 8.3% during 2026-2034.

The legionella testing market is poised for significant growth, driven by the increasing awareness of the health risks associated with Legionella bacteria and the rising demand for effective testing solutions. As outbreaks of Legionnaires' disease continue to pose a public health threat, healthcare facilities, water management companies, and regulatory bodies are prioritizing the implementation of robust testing protocols to detect and control Legionella contamination. The market encompasses a range of testing methods, including culture-based techniques, polymerase chain reaction (PCR) assays, and rapid testing kits, with advancements in technology enhancing the accuracy and speed of results.

Moreover, the growing emphasis on water quality management and safety regulations is influencing the legionella testing market. As governments and health organizations establish stricter guidelines for water systems in healthcare facilities, hotels, and public buildings, the demand for reliable testing solutions is surging. This trend is prompting manufacturers to develop innovative testing products that comply with regulatory standards and provide actionable insights for water management.

Furthermore, the increasing focus on preventive measures and risk assessment in public health is fostering innovation in the legionella testing market. Collaborations between testing laboratories, environmental agencies, and healthcare providers are driving advancements in testing methodologies and technologies, ensuring that new products meet the evolving needs of various sectors. The growing awareness of the importance of proactive legionella management in preventing outbreaks is also contributing to market growth. In summary, the legionella testing market is set for robust growth, characterized by technological advancements, a focus on regulatory compliance, and a commitment to enhancing public health safety.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Type

  • Culture Media
  • Urine Antigen Testing
  • Polymerase Chain Reaction
  • Serology
  • Direct Fluorescent Antibody

By Application

  • Water Testing
  • IVD Testing

By End-Use

  • Hospitals
  • Clinics
  • Diagnostic Labs
  • Water Treatment Industries

COMPANIES PROFILED

  • Thermo Fisher Scientific Inc, bioMrieux SA, Becton, Dickinson and Company, Qiagen NV, BioRad Laboratories, Inc, Merck KGaA, IDEXX Laboratories, Inc, Abbott Laboratories, Roche Diagnostics, ProLab Diagnostics, Inc, Eiken Chemical Co, Ltd, Hologic, Inc, Takara Bio, Inc, Phigenics, LLC, Aquacert Ltd

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL LEGIONELLA TESTING MARKET MARKET: BY TEST TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Test Type
  • 4.2. Culture Media Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Urine Antigen Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Polymerase Chain Reaction Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Serology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Direct Fluorescent Antibody Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL LEGIONELLA TESTING MARKET MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Water Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. IVD Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL LEGIONELLA TESTING MARKET MARKET: BY END-USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-use
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Diagnostic Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Water Treatment Industries Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL LEGIONELLA TESTING MARKET MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Test Type
    • 7.2.2 By Application
    • 7.2.3 By End-use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Test Type
    • 7.3.2 By Application
    • 7.3.3 By End-use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Test Type
    • 7.4.2 By Application
    • 7.4.3 By End-use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Test Type
    • 7.5.2 By Application
    • 7.5.3 By End-use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Test Type
    • 7.6.2 By Application
    • 7.6.3 By End-use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL LEGIONELLA TESTING MARKET INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Thermo Fisher Scientific Inc
    • 9.2.2 BioMAfA(C)Rieux SA
    • 9.2.3 Becton, Dickinson And Company
    • 9.2.4 Qiagen N.V
    • 9.2.5 Bio-Rad LaboratoriesInc
    • 9.2.6 Merck KGaA
    • 9.2.7 IDEXX LaboratoriesInc
    • 9.2.8 Abbott Laboratories
    • 9.2.9 Roche Diagnostics
    • 9.2.10 Pro-Lab DiagnosticsInc
    • 9.2.11 Eiken Chemical Co.Ltd
    • 9.2.12 HologicInc
    • 9.2.13 Takara BioInc
    • 9.2.14 Phigenics, LLC
    • 9.2.15 Aquacert Ltd
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제